Henderson's Chris Burvill is buying AstraZeneca, among other firms, in a move to benefit from merger and acquisition speculation.
Active fund managers must rise to the challenge of a rotation into FTSE 100 stocks after years of outperformance, wealth managers have warned.
Mid-cap stocks have suffered a harsh and indiscriminate sell-off in recent weeks, and managers have pointed to liquidity concerns as a possible trigger for the falls.
‘I am more cautious on UK growth than the crowded consensus’
UK election countdown: The start of a volatile year?
The FTSE 100 has soared to its highest level since early 2000, as mining and housing stocks boost the blue-chip index at the start of the week.
Sell-off gives Watts 'another bite of the cherry'
Fund managers are backing miners as a key income play this year, predicting the largest names in the sector will ramp up their dividend payouts after a poor first quarter.